Stevanato Group SpA (STVN) News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Stevanato Group Announces Results of Annual General Meeting

-All Resolutions Proposed to Shareholders Passed- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug...

Stevanato Group to Present at Upcoming Investor Conferences

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Stevanato Group Reports Financial Results for the First Quarter of 2024

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the...

Stevanato Group to Present at the Bank of America Securities Healthcare Conference

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the...

Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the...

Stevanato Group appoints Ugo Gay as Chief Operations Officer

Strengthening corporate leadership aims to drive operational efficiencies and standardization of global...

Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and...

Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and...

Stevanato Group Announces Public Offering of Ordinary Shares

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and...